Assam is taking a major step towards strengthening cancer care in the Northeast by partnering with Belgium-based Ion Beam Applications (IBA) to install a proton beam therapy machine in Guwahati. The initiative aims to bring advanced cancer-treatment technology closer to patients while preparing the state’s healthcare system for next-generation therapies. At the agreement-signing ceremony, Assam Chief Minister Himanta Biswa Sarma highlighted the state’s plans to adopt emerging cancer-care technologies, including Flash radiotherapy and multi-ion carbon therapy, as they become clinically available.
Proton Beam Therapy to Strengthen Cancer Treatment
Proton beam therapy uses charged particles to target cancerous tumours with precision while helping limit radiation exposure to surrounding healthy tissues. The proposed facility could expand treatment options for selected cancer patients in Assam and neighbouring Northeastern states. IBA is also exploring advanced technologies such as DynamicARC and ConformalFLASH. According to company CEO and Vice-Chairman Olivier Legrain, DynamicARC could become clinically available in approximately three years, while ConformalFLASH remains under research and clinical trials. The company has also reported progress in Flash radiotherapy through its C-FLASH-01 clinical feasibility study at Penn Medicine in the United States.
Advanced Technology Could Improve Patient Access
Beyond introducing specialised equipment, the project could help improve cancer-treatment capacity in the region. Dr Siddharth Laskar of Tata Memorial Centre, Mumbai, said Flash radiotherapy could reduce treatment-room occupancy time and allow hospitals to treat more patients using existing infrastructure. However, the success of the proposed facility will depend on trained specialists, adequate clinical infrastructure, treatment-planning systems and effective patient referral networks
Affordability and Implementation Remain Key Challenges
Although the agreement marks an important development, several details remain unclear, including the installation timeline, project cost, treatment capacity, host institution and operational model. Patient affordability will also be crucial. IBA India Director Rakesh Pathak said the company aims to bring advanced cancer-treatment technologies to India through collaborations with governments and healthcare providers. However, details regarding treatment charges, eligibility and financial assistance have not yet been announced. The proposed Guwahati facility could strengthen access to specialised cancer treatment in the Northeast. Its actual impact, however, will depend on timely implementation, clinical readiness and affordable patient access. As reported by Urban Acres, the collaboration marks a significant step towards bringing next-generation cancer-treatment technologies to Assam and strengthening the region’s healthcare infrastructure.